Breast Cancer in Pregnancy and Lactation

  • J. Huys
  • R. Monteyne
Part of the Handbuch der Medizinischen Radiologie / Encyclopedia of Medical Radiology book series (HDBRADIOL, volume 19 / 2)

Abstract

Cancer of the breast is the most common malignancy in white women. Although the highest incidence is encountered in the older age groups, figures of between 15% and 25% have been reported for the child-bearing age group (15–45 years) (Haagensen, 1971; Donegan, 1972; Brunet et al, 1977). Breast cancer and pregnancy or lactation can obviously occur either synchronously or metachronously, which implies that these conditions may influence each other. Breast cancer detected during pregnancy or lactation may have been under the influence of this special hormonal milieu, while on the other hand a pregnancy can have an effect on any residual tumor after mastectomy.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adair, F.E.: Cancer of the breast. Surg. Clin. North Am. 33, 313 (1953)Google Scholar
  2. Adams, J.B., Wong, M.S.: A correlation between uriary steroid metabolites and pathways of steroidogenesis in human breast tumor tissue. Lancet II, 1163 (1968)Google Scholar
  3. Anderson, D.E.: Some characteristic of familial breast cancer. Cancer 28, 1500–1504 (1971)PubMedGoogle Scholar
  4. Applewhite, R.R., Smith, L.R., DiVincenti, F.: Carcinoma of the breast associated with pregnancy and lactation. Am. Surg. 39, 101–104 (1973)PubMedGoogle Scholar
  5. Armstrong, B., Stevens, N., Doll, R.: Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet 2, 672–675 (1974)PubMedGoogle Scholar
  6. Barber, K.W., Dockerty, M.B., Clagett, O.T.: Inflammatory carcinoma of the breast. Surg. Gynecol. Obstet. 112, 406 (1961)PubMedGoogle Scholar
  7. Beatson, G.T.: On the treatment of inoperable cases of carcinoma of the mamma: Suggestion for a new method of treatment. Lancet 2, 104 (1896)Google Scholar
  8. Billings, R.E.: The transplantation biology of mammalian gestation. Am. J. Obstet. Gynecol 111, 469 (1971)Google Scholar
  9. Bonadonna, G.: L’état présent de la chimiothérapie adjuvante du cancer primaire du sein. Med. Hyg. 35, 4166–4170 (1977)Google Scholar
  10. Boston Collaborative Drug Surveillance Programme: Oral contraceptives and venous thromboembolic disease, surgically confirmed gall-bladder disease and breast tumours. Lancet II, 667–671 (1974)Google Scholar
  11. Boyns, A.R., Cole, E.N., Griffiths, K., Roberts, M.M., Buchan, R., Wilson, R.G., Forrest, A.P.M.: Plasma prolactin in breast cancer. Eur. J. Cancer 9, 99 (1973)PubMedGoogle Scholar
  12. Brown, J.D. cited by MacMahon. J. Natl. Cancer Inst. 50, 21–42 (1973) Etology of Human Breast Cancer: A RevewGoogle Scholar
  13. Brown, R.N.: Carcinoma of the breast followed by pregnancy. Surgery 48, 862–868 (1960)Google Scholar
  14. Brun, G., Audebert, A.: Tumeurs du sein au cours de l’état gravido-puerpéral. Bord. Med. 4, 435–446 (1973)Google Scholar
  15. Brunet, M., Jamin, M-L., Berlie, J.: Le cancer du sein chez l’homme. Nouv. Presse Méd. 6, 721–724 (1977)PubMedGoogle Scholar
  16. Bucalossi, P., Veronesi, D.: Researches on the etiological factors in human breast cancer. Acta Union. Intern. Cancer, 15, 1056–1060 (1959)Google Scholar
  17. Bunker, M.L., Peters, M.V.: Breast cancer associated with pregnancy or lactation. Am. J. Obstet. Gynecol. 85, 312–319 (1963)PubMedGoogle Scholar
  18. Byrd, B.F., Bayer, D.S., Robertson, J.C., Stephenson, S.E.: Treatment of breast tumors associated with pregnancy and lactation. Ann. Surg. 115, 940–947 (1962)Google Scholar
  19. Campion, P.D., Currey, H.L.F.: Cell-mediated immunity in pregnancy. Lancet 2, 830 (1972)PubMedGoogle Scholar
  20. Cheek, J.H.: Survey of current opinions concerning carcinoma of the breast occurring during pregnancy. A.M.A. Arch. Surg. 66, 664–672 (1953)Google Scholar
  21. Chosson, J., Ruf, H., Siragusa, A.: Considération sur quelques problèmes posés par l’association cancer du sein et grossesse. Maternité 16, 243–260 (1967)Google Scholar
  22. Cole, M.P.: Suppression of ovarian function in primary breast cancer. In: Prognostic factors in breast cancer. Forrest, T.M. (ed.), pp. 146–156. Baltimore: Williams and Wilkins Co. 1968Google Scholar
  23. Cooper, D.R., Butterfield, J.: Pregnancy subsequent to mastectomy for cancer of the breast. Ann. Surg. 171, 429–433 (1970)PubMedGoogle Scholar
  24. Craig, T.J., Comstock, G.W., Geiser, P.B.: Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls. J. Natl. Cancer Inst. 53, 1577–1581 (1974)PubMedGoogle Scholar
  25. Crosby, C.H., Barclay, T.H.: Carcinoma of the breast: Surgical management of patients with special conditions. Cancer 28, 1628–1636 (1972)Google Scholar
  26. Dargent, M.: Cancer du sein et grossesse. Eléments du pronostic. Bull. Cancer (Paris) 46, 666–682 (1959)Google Scholar
  27. Davis, M.E., Plötz, E.J.: Obstetrics, p. 233. Philadelphia: Saunders 1965Google Scholar
  28. Dickey, R.P., Minton, J.P.: L-DOPA effect on prolactin, follicle-stimulating hormone and luteinizing hormone in women with advanced breast cancer: A preliminary report. Am. J. Obstet. Gynecol. 114, 267 (1972)PubMedGoogle Scholar
  29. Dickinson, L.E., MacMahon, B, Cole, P., Brown, J.B.: Urine estrogen profiles of Oriental and Caucasian women in Hawaii. N. Engl. J. Med. 291, 1211–1213 (1974)PubMedGoogle Scholar
  30. Donegan, W.L.: Mammary carcinoma and pregnancy in cancer of the breast, p. 170–178. Philadelphia: Saunders 1967Google Scholar
  31. Donegan, W.L.: Management of pregnancy and lactation in breast cancer management. Stoll, B.A. (ed.) 1977, pp. 195–202. William Hemeram Medical Books, London.Google Scholar
  32. Dutreix, cited by Lacour, J.: Cancer du sein et grossesse. Rev. Prat. 17, 1231–1239 (1967)Google Scholar
  33. Earley, T.K., Gallagher, J.Q., Chapman, K.E.: Carcinoma of the breast in women under thirty years of age. Am. J. Surg. 118, 832–834 (1969)PubMedGoogle Scholar
  34. Ehni, G., Eckles, N.E.: Interruption of the pituitary stalk in patients with mammary carcinoma. J. Neurosurg. 16, 628–652 (1959)PubMedGoogle Scholar
  35. Engelsman, E., Heuson, J.C., Blank von der Wyst, J., Drochmans, A., Maas, H., Cheix, F., Sobrinko, L.G., Nowakowski, H.: Controlled clinical trial of L-dopa and nafoxidine in advanced heart cancer. An EORTC study. Br. Med. J. 2, 714–715 (1975)Google Scholar
  36. Eyrich, K.: Narkoseprobleme bei Schwangeren. Chirurg 42, 544–548 (1971)PubMedGoogle Scholar
  37. Fisher, B., Slack, N., Kalrych, D., Wolmark, N.: Ten year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg. Gynecol. Obstet. 140, 528–534 (1975)PubMedGoogle Scholar
  38. Fisher, E., Gregorio, R., Fisher, B.: Prognostic significance of histopathology. In: Risk factors in breast cancer. Stoll, B.A. (ed.), 83–109. Heineman Medical Books 1976 LondonGoogle Scholar
  39. Franks, S., Ralphs, D.N.L., Seagrott, V., Jacobs, H.S.: Prolactin concentrations in patients with breast cancer. Br. Med. J. 4, 320–321 (1974)PubMedGoogle Scholar
  40. Frantz, A.G., Hobif, D.V., Hyman, G.A., Sub, H.K., Sassin, J.F., Zimmerman, E.A., Noel, G.L., Bleinberg, D.L.: In: Human prolactin. Pasteeis, J.L., Robyn, C. (eds.), pp. 273–290 Excerpta Medica 1973 AmsterdamGoogle Scholar
  41. Friesen, H.G., Guyda, H., Hwang, P., Tyson, J.E., Barbeau, A.: Functional evaluation of prolactin secretion. A guide to therapy. J. Clin. Invest. 51, 706–709 (1972)PubMedGoogle Scholar
  42. Grattarola, R.: The premenstrual endometrial pattern of women with breast cancer. Cancer 17, 1119–1122 (1964)PubMedGoogle Scholar
  43. Guerzon, P.G., Pearson, O.H.: Lergotrile Mesylate, a new prolactin inhibitor drug. Clin. Res. 22, 632 (1974)Google Scholar
  44. Haagensen, C.D.: Cancer of the breast in pregnancy and during lactation. Am. J. Obstet. Gynecol. 98, 141–150 (1967)PubMedGoogle Scholar
  45. Haagensen, C.D.: Disease of the breast. Philadelphia: Saunders 1971Google Scholar
  46. Haagensen, C.D., Stout, A.P.: Carcinoma of the breast: Criteria of operability. Ann. Surg. 118, 1032 (1943)PubMedGoogle Scholar
  47. Haines, R.F., Tsai, C., Crudup, T.W., Turcotte, J.G.: Rabbit renal allograft survival prolongation by a synthetic progestin. Transplant. Abstr. 124, 410 (1972)Google Scholar
  48. Harrington, S.W.: Carcinoma of the breast. Results of surgical treatment when the carcinoma occured in the course of pregnancy or lactation and when pregnancy occured subsequent to operation. Ann. Surg. 106, 690–700 (1937)PubMedGoogle Scholar
  49. Heinomen, O.P., Shapiro, S., Tuominen, L., Turuner, M.I.: Reserpine use in relation to breast cancer. Lancet 2, 675–677 (1974)Google Scholar
  50. Hellman, L., Fishman, J., Zumoff, B., Cassouto, J., Gallagher, T.F.: Studies of estradiol transformation in women with breast cancer. J. Clin. Endocrinol. Metab. 27, 1087–1089 (1967)PubMedGoogle Scholar
  51. Hellman, L., Zummoff, B., Fishman, J., Gallagher, T.F.: Peripheral metabolism of 3H-estradiol and the excretion of endogen ous estrone and estriol glucosiduronate in women with breast cancer. J. Clin. Endocrinol. Metab. 33, 138 (1971)PubMedGoogle Scholar
  52. Helman, P., Bennett, M.B.: Breast cancer and pregnancy. S. Afr. Med. J. 37, 1236 (1963)Google Scholar
  53. Henderson, B.E., Powell, D., Rosario, I.: An epidemiological study of breast cancer. J. Natl. Cancer Inst. 53, 609–614 (1974)PubMedGoogle Scholar
  54. Henderson, B.E., Gerkins, V., Rosario, I., Cassagranole, J., Pike, M.C.: Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N. Engl. J. Med. 293, 790–795 (1975)PubMedGoogle Scholar
  55. Heuson, J.C., Coume, A., Staquet, M.: Clinical trial of 2-Br-ergocryptine in advanced breast cancer. Eur. J. Cancer 8, 155–156 (1972)Google Scholar
  56. Hochman, A., Schreiber, H.: Pregnancy and cancer of the breast. Obstet. Gynecol. 2, 268–276 (1953)PubMedGoogle Scholar
  57. Holleb, A.I., Farrow, J.H.: The relation of carcinoma of the breast and pregnancy in 283 patients. Surg. Gynecol. Obstet. 115, 65 (1962)PubMedGoogle Scholar
  58. Holleb, A.J., Farrow, J.H.: The relation of carcinoma of the breast and pregnancy in 283 cases. Acta Union. Int. Cancer 20, 1480 (1964)Google Scholar
  59. Horsely, J.S., Airich, E.M., Wright, C.B.: Carcinoma of the breast in women 35 years of age or younger. Ann. Surg. 839–843 (1969)Google Scholar
  60. Huggins, C., Jensen, E.V.: The depression of estrone induced uterine growth by phenolic estrogens with oxygen functions at position 6 or 16: The impeded estrogens. J. Exp. Med. 102, 335–346 (1955)PubMedGoogle Scholar
  61. Huggins, C., Torralba, Y., Mainzer, K.: Hormonal influences on mammary tumours of the rat. 1. Acceleration of growth of transplanted fibro-adenoma in ovariectomized and hypophysectomized rats. J. Exp. Med. 104, 525 (1956)PubMedGoogle Scholar
  62. Huggins, C., Briziarelli, G., Sutton, H.: Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J. Exp. Med. 109, 25–41 (1959)PubMedGoogle Scholar
  63. Hwang, P., Guyda, H., Friesen, H.: A radioimmunoassay for human prolactin. Proc. Natl. Acad. Sci. USA 68, 1902 (1971)PubMedGoogle Scholar
  64. Jacobs, L.S., Marez, I.K., Panghaday, W.H.: A mixed heterologous radioimmunoassay for human prolactin. J. Clin. Endocrinol. Metab. 34, 484–500 (1972)PubMedGoogle Scholar
  65. Kaye, M.P., Jones, W.R.: Effect of human chorionic gonadotropin on in vitro lymphocyte transformation. Am. J. Obstet. Gynecol. 109, 1029 (1971)PubMedGoogle Scholar
  66. Kennedy, B.J.: Hormonal therapies in breast cancer. Semin. Oncol. 1, 119–130 (1974)PubMedGoogle Scholar
  67. Kilgore, A.R., Bloodgood, J.C.: Tumors and tumorlike lesions of the breast in association with pregnancy and lactation. Arch. Surg. 18, 2079 (1929)Google Scholar
  68. Kleinberg, D.L., Noel, G.L., Frantz, A.G.: Chlorpromasine stimulation and L-DOPA suppression of plasma prolactin in man. J.Clin. Endocrinol. Metab. 33, 873 (1971)Google Scholar
  69. Kwa, H.G., De Jong-Bakker, M., Engelsman, E., Cleton, F.G.: Plasma prolactin in human breast cancer. Lancet i, 433–434 (1974)Google Scholar
  70. Lacour, J., Mourali, N, Weiler, J., Denoix, P.: Cancer du sein et grossesse. Rev. Prat. 17, 1231–1239 (1967)Google Scholar
  71. Lane-Claypon, J.E.: A further report on cancer of the breast with special reference to its associated antecedent conditions. Rep. Public Health 32, Ministry of Health London 1926Google Scholar
  72. Lemon, A.M., Wotiz, H.H., Parsons, L., Mozden, P.J.: Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. J. Am. Med. Assoc. 196, 1128 (1966)Google Scholar
  73. Lemon, H.M.: Abnormal metabolism and tissue estrogen receptor proteins in breast cancer. Cancer 25, 423–433 (1970)PubMedGoogle Scholar
  74. Lemon, H.M.: Oestriol and prevention of breast cancer. Lancet I, 546–547 (1973)Google Scholar
  75. Lerger, J.E., Jimenez, E., Maldonado, N., Veray, F.: Normal pregnancy in multiple myeloma treated with cyclophosphamide. Cancer 34, 1018–1022 (1974)Google Scholar
  76. Lerner, L.J., Hilf, R.: Biological activities of steroids and their relationship to breast cancer therapy. In: Current concepts of breast cancer, p. 80. Baltimore: Williams & Wilkins 1967Google Scholar
  77. Lerner, L.J., Bianchi, A., Dzelkalns, H., Borman, A.: Effect of testosterone, estradiol, progesterone and hydorxyprogesterone caproate on the growth of a mammary tumor in mice. Proc. Am. Assoc. Cancer Res. 6, 39 (1965)Google Scholar
  78. Leurson, E.F.: Breast cancer and pregnancy or lactation. Int. Abstr. Surg. 99, 417–424 (1954)Google Scholar
  79. Levin, M.L., Sheehe, P.R., Graham, S., Glidewell, O.: Lactation and menstrual function as related to cancer of the breast. Am. J. Public Health 54, 580–587 (1964)Google Scholar
  80. Lewison, E.F.: Collective Review Breast Cancer and Pregnancy or Lactator. Surg. Gynec. and Obst. 99, 417–424, 1954Google Scholar
  81. L’Hermite, M., Robyn, C.: Prolactine hypophysäre humaine, detection radioimmunologique et taux au cours de la grossesse. Ann. Endocrinol (Paris) 33, 357 (1972)Google Scholar
  82. Lillienfield, A.M.: The epidemiology of breast cancer. Cancer Res. 23, 1503–1513 (1963)Google Scholar
  83. Lin, T.M., Chen, R.P., MacMahon, B.: Epidemiologic characteristics of cancer of the breast in Taiwan. Cancer 27, 1497–1504 (1971)PubMedGoogle Scholar
  84. Lipsett, M.B.: Oestrogen profiles and breast cancer. Lancet II, 1378 (1971)Google Scholar
  85. MacCormick, G.M., Moon, R.C.: Effect of increasing doses of estrogen and progesterone on mammary carcinogenesis in the rat. Eur. J. Cancer 9, 483–486 (1973)Google Scholar
  86. Mack, T.M., Henderson, B.E., Girkins, U.R.: Reserpine and breast cancer in a retirement community. N. Engl. J. Med. 292, 1366–1371 (1975)PubMedGoogle Scholar
  87. MacMahon, B, Cole, P.: Endocrinology and epidemiology of breast cancer. Cancer 24, 1146–1150 (1969)PubMedGoogle Scholar
  88. MacMahon, B., Feinleib, M.: Breast cancer in relation to nursing and menopausal history. J. Natl Inst. 24, 733–753 (1960)Google Scholar
  89. MacMahon, B, Lin, T.M., Lowe, C.R.: Lactation and cancer of the breast. A summary of an international study. Bull. WHO 42, 185–194 (1970)PubMedGoogle Scholar
  90. MacMahon, B., Cole, P., Brown, J.B., Aoki, K., Lin, T., Morgan, R., Woo, N.: Oestrogen profiles of Asian and North American women. Lancet II, 900 (1971)Google Scholar
  91. MacMahon, B., Cole, P., Brown, J.: Etiology of human breast cancer. A review. J. Natl. Cancer Inst. 50, 21–42 (1973)Google Scholar
  92. MacMahon, B., Cole, P., Brown, J.P.: Urine oestrogen profiles of Asian and North American Women. Int. J. Cancer 14, 161–167 (1974)PubMedGoogle Scholar
  93. Marmorsten, J., Crowley, L.G., Myers, S.M., Stern, E., Hopkins, G.E.: Urinary excretion of estrone, estradiol and estriol by patients with breast cancer and beningn breast disease. Am. J. Obstet. Gynecol. 92, 460–467 (1965)Google Scholar
  94. Meakin, J.W.: Ovarian irradiation and prednisone following surgery for carcinoma of the breast. In: Adjuvant therapy of cancer. Salmon, Jones, Elsevier North Holland 1977Google Scholar
  95. Meyer, M.F.: Breast feeding in the United States. Clin. Pediatr. (Phila) 9, 708 (1968)Google Scholar
  96. Michal, A., Torres, J.E., Mule, J.G.: Carcinoma of the breast in pregnancy and laction. Ann. Surg. 29, 509 (1963)Google Scholar
  97. Miller, H.K.: Cancer of the breast during pregnancy and lactation. Am. J. Obstet. Gynecol. 83, 607–612 (1962)PubMedGoogle Scholar
  98. Miller, M.J., Noble, R.L.: Effects of exogenous hormones on growth characteristics and morphology of transplanted mammary fibroadenoma of the rat. Br. J. Cancer 8, 495–507 (1954)Google Scholar
  99. Minton, J.P.: The response of breast cancer patients with bone pain to L-dopa. Cancer 33, 358–363 (1974)PubMedGoogle Scholar
  100. Minton, J.P., Dickey, R.P.: Prolactin, F.S.H. and L.H. in breast cancer: Effect of levadopa and oophorectomy. Lancet I, 1069–1070 (1972)Google Scholar
  101. Montgomery, T.L.: Detection and disposal of breast cancer. Am. J. Obstet. Gynecol. 81, 926 (1961)PubMedGoogle Scholar
  102. Moore, D.H.: Evidence in favor of the existence of human breast cancer virus. Cancer Res. 34, 2322 (1974)PubMedGoogle Scholar
  103. Muggia, F.M., Kasclleth, P.A., Ochea, M., Flatow, F.A., Gelrom, A., Hyman, G.A., treatment of heart cancer with nedoxyprogesterone. Am. J. Med. 68, 328–337, 1968Google Scholar
  104. Munroe, J.S.: Progesteroids as immunosuppressive agents. J. Reticuloendothel. Soc. 9, 361 (1971)PubMedGoogle Scholar
  105. Nevinny, A.B, Nevinny, D., Rosoff, C.B., Hall, T.C., Muench, H.: Prophylactic oophorectomy in breast cancer therapy. Preliminary report. Am. J. Surg. 117, 531 (1969)Google Scholar
  106. Nissen-Meyer, R.: Suppression of ovarian function in primary breast cancer. In: Prognostic factors in breast cancer. Williams and Forrest, pp. 139–145. Wilkins, Baltimore 1968Google Scholar
  107. Nokin, J., Vekemans, M., L’Hermite, H., Robyn, C.: Arcadian periodicity of serum prolactin concentration in man. Br. Med. J. 3, 561 (1972)PubMedGoogle Scholar
  108. O’Fallon, W.M., Labarthe, D.R., Kurland, L.T.: Rauwolfia derivatives and breast cancer. Lancet 2, 292–296 (1975)PubMedGoogle Scholar
  109. Papaioannou, A.N.: The etiology of human breast cancer. Berlin, Heidelberg, New York: Springer 1974Google Scholar
  110. Peters, M.V.: Carcinoma of the breast associated with pregnancy. Radiology 78, 58–67 (1962)PubMedGoogle Scholar
  111. Peters, M.V.: The effect of pregnancy in breast cancer. In: Prognostic factors in breast cancer. Forrest (ed.), pp. 65–80. Williams and Wilkins, Baltimore 1968Google Scholar
  112. Poel, W.E.: Progesterone enhancement of mammary development as a model of carcinogenesis. Br. J. Cancer 22, 867–873 (1968)PubMedGoogle Scholar
  113. Purtilo, D.T., Hallgren, H.M., Yunis, E.J.: Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy. Lancet I, 769–770 (1972)Google Scholar
  114. Ravdin, R.G., Lewison, E.F., Slack, N.H., Gardner, B, State, D., Fisher, B.: Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. Surg. Gynecol. Obstet. 131, 1055 (1970)PubMedGoogle Scholar
  115. Rissanen, P.M.: Carcinoma of the breast during pregnancy and lactation. Br. J. Cancer 22, 663–668 (1968)PubMedGoogle Scholar
  116. Rissanen, P.M.: Pregnancy following treatment of mammary carcinoma. Acta Radiol. 8, 415–422 (1969)Google Scholar
  117. Robbins, G.F., Shah, J., Rosen, P., Chu, F., Taylor, J.: Inflammatory carcinoma of the breast. Surg. Clin. North Am 54, 801–810 (1974)PubMedGoogle Scholar
  118. Rolly, G.: Anesthesie bij de zwangere vrouw. Tijdschr. Geneeskd. 16, 791–799 (1966)Google Scholar
  119. Rosemond, G.P.: Carcinoma of the breast during pregnancy. Clin. Obstet. Gynecol. 6, 994–1001 (1963)Google Scholar
  120. Rosemond, G.P.: Management of patients with carcinoma of the breast in pregnancy. Ann. N.Y. Acad. Sci. 114, 851–856 (1964)Google Scholar
  121. Rosemond, G.P., Mauer, W.P.: The complication of pregnancy on breast cancer. In: Breast cancer: Early and late, (ed), pp. 227–235. Yeark Book Medical Chicago 1970Google Scholar
  122. Sassin, J.F., Frantz, A.G., Wertzman, E.D., Kapen, S.: Human prolactin: 24-hour pattern with increased release during sleep. Science 177, 1205 (1972)PubMedGoogle Scholar
  123. Sassin, J.F., Frantz, A.G., Kapen, S., Wertzman, E.D.: The nocturnal release of human prolactin is dependent on sleep. J. Clin. Endocrinol. Metab. 37, 436–440 (1973)PubMedGoogle Scholar
  124. Schlom, T., Spiegelman, S.: Breast cancer: Molecular bases for a viral etiology. N.Y. State J. Med. 74, 1373 (1974)PubMedGoogle Scholar
  125. Segi, M., Fukushima, L., Fujisaku, S.: An epidemiological study on cancer in Japan. Gann 48, Suppl., 1–63 (1957)Google Scholar
  126. Sherman, B.M., Korenman, S.G.: Inadequate Corpus luteum function: A pathological interpretation of human breast cancer epidemiology. Cancer 33, 1306–1312 (1974)PubMedGoogle Scholar
  127. Shubic, P., Hartwell, J.L.: Survey of compounds which have been tested for carcinogenic activity. Washington D.C.: U.S. Government Printing Office 1957Google Scholar
  128. Smith, J.K., Caspary, E.A., Field, E.J.: Immune responses in pregnancy. Lancet I, 96 (1972)Google Scholar
  129. Smithers, D.W.: Family histories of 459 patients with cancer of the breast. Br. J. Cancer 2, 163–167 (1948)PubMedGoogle Scholar
  130. Stevenson, R.E.: The fetus and newly born infant. St. Louis: Mosby 1973Google Scholar
  131. Stoll, B.A.: Brain catecholamines and breast cancer: A hypothesis. Lancet I, 431 (1972)Google Scholar
  132. Stoll, B.A.: Effect of age on growth pattern. In: Risk factors in breast cancer. Stoll, B.A. (ed.), pp. 129–148. Heinemann Medical Books 1976 LondonGoogle Scholar
  133. Stoll, B.A., Dexens, S.: Effect of pregnancy and lactation on prognosis in risk factors in breast cancer. Stoll, B.A. (ed.), pp. 164–172. Heineman Medical Books 1976 LondonGoogle Scholar
  134. Strelkavskos, A.J., Wilson, B.S., Dray, S., Podson, M.: Inversion of levels of human T and B cells in early pregnancy. Nature D, 331 (1975)Google Scholar
  135. Taylor, G.W., Meitzer, A.: Inflammatory carcinoma of the breast. Am. J. Cancer 32, 33–49 (1938)Google Scholar
  136. Treves, N., Holleb, A.I.: A report on 549 cases of breast cancer in women 35 years or younger. Surg. Gynecol. Obstet. 107, 271–283 (1958)PubMedGoogle Scholar
  137. Turbinkton, R.W., Underwood, L.E., Van Wyk, J.J.: Elevated serum prolactin levels after pituitary-salk section in man. N. Engl. J. Med. 285, 707–710 (1971)Google Scholar
  138. Valaoras, U.G., MacMahon, B, Tuchopoulos, D., Polychronopoulou, A.: Lactation and reproduction histories of breast cancer patients in greater Athens 1965–1967. Int. J. Cancer 4, 350–363 (1969)PubMedGoogle Scholar
  139. Wainwright, J.M.: Comparison of conditions associated with breast cancer in Great Britain and America. Am. J. Cancer 15, 2610–2645 (1931)Google Scholar
  140. White, T.T.: Prognosis of breast cancer for pregnant and nursing women. Surg. Gynecol. Obstet. 100, 661–666 (1955)PubMedGoogle Scholar
  141. White, T.T., White, W.C.: Breast cancer and pregnancy. Ann. Surg. 144, 384 (1956)PubMedGoogle Scholar
  142. Wilson, R.G., Buchan, R., Roberts, M.M.: Plasma prolactin and breast cancer. Cancer 33, 1325 (1974)PubMedGoogle Scholar
  143. Wotiz, H.H., Shane, J.A., Vigersky, R., Bretcher, P.J.: The regulatory role of estriol in proliferative action of estradiol. In: Prognostic factors in breast cancer, p. 368. Williams & Wilkins 1968Google Scholar
  144. Wynder, E.L.: Current concepts of the etiology of breast cancer. In: Prognostic factors in breast cancer, p. 32. Williams & Wilkins 1968Google Scholar
  145. Wynder, E.L., Broos, I.J., Hirayama, T.: A study of the epidemiology of cancer of the breast. Cancer 13, 733–753 (1960)Google Scholar
  146. Yuasa, S., MacMahon, B.: Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull. WHO 42, 192–204 (1970)Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1982

Authors and Affiliations

  • J. Huys
  • R. Monteyne

There are no affiliations available

Personalised recommendations